Zoekresultaten - 52 results
How to evaluate emerging technologies in cervical cancer screening?
biomarkers and protect clinicians and stakeholders against premature claims for insufficiently evaluated products. Health Topics: Quality of healthcare Category: A1 FOS Classification: 3.03 Health sciences ...
Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.
genes and showed that the selected phages 14/1, PNM and ISP are close relatives of respectively F8, phiKMV and phage G1. The bacteriophage cocktail is currently being evaluated in a pilot clinical study ...
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
Neoplasms Vaginal Smears Abstract: Cervical cancer is the main cancer among women in sub-Saharan Africa, India and other parts of the developing world. Evaluation of screening performance of effective, ...
Burden of cervical cancer in Europe: estimates for 2004.
member states. In order to evaluate the impact of existing and new prevention methods, regularly updated information on the burden of cervical cancer is needed. The best estimates of mortality and ...
Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
The recognition of a strong etiological relationship between infection with high-risk human papillomavirusses and cervical cancer has prompted research to develop and evaluate prophylactic and ...
Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
review procedures, aiming for optimization of accuracy, are described throughout the literature. Evaluation and synthesis of those methods are needed. In a previous study, we pooled data on the diagnostic ...
Eurosentinel: development of an international sentinel network of general practitioners.
deals with the purposes of the project, the studies carried out in the frame of the project, and an evaluation of three years Eurosentinel. Health Topics: Quality of healthcare Category: A1 FOS ...
Detection of false negative Pap smears by rapid reviewing. A metaanalysis.
(SIL) and 0.02% (CI:.01-.03) for high grade SIL. The false negative rate of primary screening, evaluated by RR, was 2.0% (CI: 1.5-2.6) for all cytologic abnormalities and 1.4% (CI:.8-2.1) for high grade ...
Cost-DALY comparison of hip replacement care in 12 Belgian hospitals
institutions, the average cost (SD) of a stay being €8013 (€4304). Our model allowed us to identify hospitals with observed values higher than those predicted. Out of the 12 hospitals evaluated, 4 need to reduce ...
CanCon European Guide on Quality Improvement in Comprehensive Cancer Control- Chapter 4: Screening
guiding further improvement. Evaluations of the benefit-harm balance and cost-effectiveness of screening are required periodically for existing programmes and prospectively for new screening programmes. ...